Associated variables with the clinical outcome of hospitalized COVID-19 patients
DOI:
https://doi.org/10.11606/issn.1679-9836.v100i5p431-441Keywords:
COVID-19, 2019 New Coronavirus, Comorbidity, Measures of association, Exposure, Risk or outcome, Hospitalized patientsAbstract
Introduction: Understanding the pathophysiology of COVID-19 and factors associated with the severe evolution of this disease is essential for the establishment of better preventive, diagnostic and therapeutic approaches to combat the new coronavirus. Objective: To identify the sociodemographic and clinical characteristics associated with the clinical outcome of hospitalized patients diagnosed with COVID-19 in a private service in a city in the interior of São Paulo. Method: Data from 117 hospitalized patients diagnosed with COVID-19, seen from July to December 2020, were included. The data were analyzed through Pearson’s non-parametric chi-square test and Fisher’s exact test, with a 5% level of statistical significance (p <0.05). Results: Most hospitalized patients are male, aged between 61 and 70 years, in the ward for 8.7 days, and 29.9% died. Hypertension and low oxygen saturation represented, respectively, the most frequent comorbidity and severity factor. Conclusions: Among hospitalized patients diagnosed with COVID-19, the clinical outcome was associated with severity factors, age group and impaired renal function.
Downloads
References
World Health Organization. Coronavirus disease (COVID-19) pandemic, 2021. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
Brasil. Ministério da Saúde. Painel Coronavírus. Brasília, DF; 2021. Disponível em: https://covid.saude.gov.br/.
Brasil. Ministério da Saúde. Diretrizes para diagnóstico e tratamento da COVID-19. Brasília, DF; 2020. Disponível em: https://saude.rs.gov.br/upload/arquivos/202004/14140600-2-ms-diretrizes-covid-v2-9-4.pdf.
Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2021;19(3):171-83. doi: 10.1038/s41579-020-00461-z.
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669-77. doi: 10.1016/S1473-3099(20)30243-7.
Bonanad C, García-Blas S, Tarazona-Santabalbina F, Sanchis J, Bertomeu-González V, Fácila L, et al. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21(7):915-8. doi: 10.1016/j.jamda.2020.05.045.
Centers for Disease Control and Prevention. CDC updates, expands list of people at risk of severe COVID-19 illness. United States; 2020. Available from: https://www.cdc.gov/media/releases/2020/p0625-update-expands-covid-19.html.
Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058.
Tavares CAM, Avelino-Silva TJ, Benard G, Cardozo FAM, Fernandes JR, Girardi ACC, et al. Alterações da ECA2 e fatores de risco para gravidade da COVID-19 em pacientes com idade avançada. Arq Bras Cardiol. 2020;115(4):701-7. Disponível em: http://abccardiol.org/en/article/ace2-expression-and-risk-factors-for-covid-19-severity-in-patients-with-advanced-age/
Bao J, Li C, Zhang K, Kang H, Chen W, Gu B. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta. 2020;509:180-94. doi:10.1016/j.cca.2020.06.009
Dalia T, Lahan S, Ranka S, Acharya P, Gautam A, Goyal A, et al. Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: a systematic review and meta-analysis. Indian Heart J. 2021;73(1):91-8. doi: 10.1016/j.ihj.2020.12.002
Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, et al. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis. 2020;96:467–74. doi: 10.1016/j.ijid.2020.05.055
Xavier AR, Silva JS, Almeida JPCL, Conceição JFF, Lacerda GS, Kanaan S. COVID-19: clinical and laboratory manifestations in novel coronavirus infection. J Bras Patol Med Lab. 2020;56:e3232020. https://doi.org/10.5935/1676-2444.20200049
Fundação Oswaldo Cruz (FIOCRUZ). Observatório COVID-19. Cobertura e positividade dos testes para SARS-CoV-2. Evolução, tendências recentes e recomendações. Nota Técnica 16, 28 de dezembro de 2020.
Johns Hopkins Coronavirus Resource Center. Which U.S. States meet recommended testing criteria? Baltimore: Johns Hopkins Coronavirus Resource Center; 2021. Available from: https://coronavirus.jhu.edu/testing/testing-positivity
WorldOMeter. COVID-19 coronavirus pandemic. Reported cases and deaths by country or territory [cited 06 August 2021]. Available from: https://www.worldometers.info/coronavirus/
Agência Brasil. Covid-19: boletim aponta aumento de 6% dos casos e 11% das mortes. Disponível em: https://agenciabrasil.ebc.com.br/saude/noticia/2020-12/covid-19-boletim-aponta-aumento-de-6-dos-casos-e-11-das-mortes
Ranzani OT, Bastos LSL, Gelli JGM, Marchesi JF, Baião F, Hamacher S, et al. Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021;9(4):407-18. doi: 10.1016/S2213-2600(20)30560-9.
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052-9. https://doi.org/10.1001/jama.2020.6775.
Nepomuceno MR, Acosta E, Alburez-Gutierrez D, Aburto JM, Gagnon A, Turra CM. Besides population age structure, health and other demographic factors can contribute to understanding the COVID-19 burden. Proc Natl Acad Sci. 2020;117(25):13881-3. doi: 10.1073/pnas.2008760117.
Lana RM, Coelho FC, Gomes MFC, Cruz OG, Bastos LS, Villela DAM, et al. Emergência do novo coronavírus (SARS-CoV-2) e o papel de uma vigilância nacional em saúde oportuna e efetiva. Cad Saude Publica. 2020;36(3):e00019620. https://doi.org/10.1590/0102-311x00019620
Killerby ME, Link-Gelles R, Haight SC, Schrodt CA, England L, Gomes DJ, et al. Characteristics associated with hospitalization among patients with COVID-19 — Metropolitan Atlanta, Georgia, March–April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(25):790-4. doi: 10.15585/mmwr.mm6925e1.
Ruíz-Quiñonez JA, Guzmán-Priego CG, Nolasco-Rosales GA, Tovilla-Zarate CA, Flores-Barrientos OI, Narváez-Osorio V, et al. Features of patients that died for COVID-19 in a hospital in the south of Mexico: a observational cohort study. Di Gennaro F, editor. PLoS One. 2021;16(2):e0245394. doi: 10.1371/journal.pone.0245394.
Macedo MCF, Pinheiro IM, Carvalho CJL, Fraga HCJR, Araujo IPC, Montes SS, et al. Correlation between hospitalized patients’ demographics, symptoms, comorbidities, and COVID-19 pandemic in Bahia, Brazil. Adrish M, editor. PLoS One. 2020;15(12):e0243966. doi: 10.1371/journal.pone.0243966.
Wenham C, Smith J, Morgan R. COVID-19: the gendered impacts of the outbreak. Lancet. 2020;395(10227):846-8. doi: 10.1016/S0140-6736(20)30526-2.
Magalhães JJF, Mendes RPG, Silva CTA, Silva SJR, Guarines KM, Pena L. Epidemiological and clinical characteristics of the first 557 successive patients with COVID-19 in Pernambuco state, Northeast Brazil. Travel Med Infect Dis. 2020;38:101884. doi: 10.1016/j.tmaid.2020.101884.
Brasil. Ministério da Saúde. Sistema Único de Saúde. Secretaria de Vigilância em Saúde. Coronavírus Brasil. Disponível em: https://covid.saude.gov.br/.
Shahbazi F, Solgi M, Khazaei S. Predisposing risk factors for COVID-19 infection: a case-control study. Casp J Intern Med. 2020;11(Suppl 1):495-500. doi: 10.22088/cjim.11.0.495
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2027-34. doi: 10.1093/cid/ciaa344.
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543-58. doi: 10.1038/s41569-020-0413-9.
Savoia C, Volpe M, Kreutz R. Hypertension, a moving target in COVID-19: current views and perspectives. Circ Res. 2021;128(7):1062-1079. doi:10.1161/CIRCRESAHA.121.318054
Shibata S, Arima H, Asayama K, Hoshide S, Ichihara A, Ishimitsu T, et al. Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19. Hypertens Res. 2020;43(10):1028-46. doi: 10.1038/s41440-020-0515-0
Lim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17(1):11-30. doi: 10.1038/s41574-020-00435-4
Gupta S, Mitra A. Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-2. Heart Fail Rev. 2021;1-11. doi: 10.1007/s10741-021-10076-y.
Cagnin A, Di Lorenzo R, Marra C, Bonanni L, Cupidi C, Laganà V, et al. Behavioral and psychological effects of coronavirus disease-19 quarantine in patients with dementia. Front Psychiatry. 2020;11:578015. doi: 10.3389/fpsyt.2020.578015
Kwok S, Adam S, Ho JH, Iqbal Z, Turkington P, Razvi S, et al. Obesity: a critical risk factor in the COVID‐19 pandemic. Clin Obes. 2020;10(6):e12403. doi: 10.1111/cob.12403.
Gerotziafas GT, Catalano M, Colgan M-P, Pecsvarady Z, Wautrecht JC, Fazeli B, et al. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost. 2020;120(12):1597-1628. doi: 10.1055/s-0040-1715798
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.
Pfister F, Vonbrunn E, Ries T, Jäck H-M, Überla K, Lochnit G, et al. Complement Activation in Kidneys of Patients With COVID-19. Front Immunol. 2021;11:594849. doi: 10.3389/fimmu.2020.594849.
Minas Gerais. Secretaria de Estado de Saúde. Plano de Contingência Operativo para Infecção Humana pelo SARS COV-2 (doença pelo Coronavírus – COVID-19) da Macrorregião Oeste. Versão 2.0. 2020. Disponível em: https://coronavirus.saude.mg.gov.br/images/anexos/plano-contingencia/30-07_Plano-de-Contingencia_Oeste.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Vagner Luís Desiderio, Vania Fabio, Evelin Capellari Carnio, Simone de Godoy, Hadder Batista Silva, Leila Maria Marchi-Alves
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
